India has granted a customs duty waiver on 40 petrochemical inputs until June 30, 2026. The aim is to ease the burden on pharmaceutical and medical device manufacturers facing raw material price hikes due to the West Asia conflict. The waiver covers critical...
In this blog, we will discuss the common causes of low-quality product in pharma industry. Additionally, we will present the consequences of low-quality products and how companies prevent them. What is considered a low-quality product in pharma industry? In the...
A pharmaceutical cleanroom is a highly controlled environment designed to minimize contamination during drug manufacturing. Airborne particles, temperature, humidity, and pressure are strictly regulated in a clean room. Setting up a pharma cleanroom requires a...
A supplier audit in pharma is a formal evaluation of vendors providing raw materials, packaging, or services. The aim is to ensure they comply with Good Manufacturing Practices (GMP), regulatory standards, and quality expectations. It is a critical part of...
India’s parliamentary panel has recommended decentralising medical device approvals to State Licensing Authorities. The aim is to reduce delays, improve efficiency, and strengthen competitiveness. The reforms target bottlenecks in CDSCO processes, especially for...